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Abstract
Cervical degenerative disc disease (CDDD) can lead to radiculopathy and 
myelopathy, resulting in pain, lack of function, and immobility. Anterior cervi-
cal discectomy and fusion (ACDF) is a common surgical treatment modality 
for advanced CDDD. ACDF involves removal of the affected disc(s) followed 
by replacement with a bone or synthetic graft. Historically, autograft has been 
considered the gold standard for interbody fusion. However, it is often associated 
with limitations, including donor site morbidity and limited quality and supply, 
prompting surgeons to seek alternatives. Two of the most common alternatives 
are structural bone allografts and polyetheretherketone (PEEK) synthetic cages. 
Both, advantageously, have similar mechanical properties to autologous bone, with 
comparable elastic modulus values. However, a lack of osseointegration of PEEK 
cages has been reported both pre-clinically and clinically. Reported fusion rates 
assessed radiographically are higher with the use of structural bone allografts com-
pared to PEEK cages, while having a lower incidence of pseudarthrosis. This book 
chapter will discuss in detail the pre-clinical and clinical performance of structural 
allografts in comparison to conventional PEEK cages.
Keywords: polyetheretherketone (PEEK), structural bone allograft, anterior cervical 
discectomy and fusion (ACDF), cervical degenerative disc disease, synthetic cage, 
allograft, irradiation
1. Introduction
Cervical degenerative disc disease is one of the most common diagnoses for 
patients suffering from neck and back pain. These symptoms may present with various 
conditions, such as radiculopathy or myelopathy, involving compression of the nerve 
root and spinal cord, respectively [1]. Patients may suffer from pain, lack of func-
tion, immobility and sensory loss. Initial treatments often include anti-inflammatory 
medicine, immobilization, and physical therapy [1]. However, when conservative 
treatment options fail, a surgical approach such as anterior cervical discectomy and 
fusion (ADCF) may be warranted. This anterior approach involves excising the 
affected disc(s), removing osteophytes, and decompressing the nerve root or spinal 
cord. Following disc removal, the residual vertebral space is typically implanted with 
a bone or synthetic graft, with or without the additional support of plates and screws. 
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Robinson and Smith described this technique in 1955 [2]. Their approach involved 
implantation of a horseshoe-shaped bone graft harvested from iliac crest, followed by 
immobilization. Patients treated with this technique demonstrated promising clinical 
outcomes [2]. In 1958, Cloward described a similar technique, however, it included 
decompression of the neural structures and implantation of a bone dowel in the 
interbody space [3]. Regardless of the approach, a graft was used as a spacer to restore 
disc height, provide stability, and help promote bone fusion. Autograft, generally 
taken from the iliac crest, is often considered to be the gold standard for interbody 
fusion [4]. The use of autograft has led to high fusion rates and clinical success, 
although there are several disadvantages, such as extended operating time, donor site 
pain, limited supply, and variable quality depending upon the patient’s health [5–8]. In 
an effort to avoid the complications seen with autografts, there has been a decades-old 
shift towards the use of alternative interbody spacers for treatment of degenerative 
disc disease [9, 10]. Two of the most common choices have been structural allograft 
bone or synthetic cages manufactured using polyetheretherketone (PEEK) [10]. 
Here, a comparison of the material properties and clinical performance of structural 
allografts and conventional PEEK cages is provided.
2. Bone graft substitutes as intervertebral spacers in ACDF
Structural bone allografts have been used successfully in a broad range of clinical 
applications including ACDF procedures [11–13]. Although lacking direct osteogenic 
potential, structural allografts have similar osteoconductive properties to autograft 
while avoiding complications such as donor site morbidity [14]. Furthermore, studies 
have shown similar clinical outcomes when comparing the use of allograft to autograft 
in ACDF procedures [15, 16]. Other commonly used implants include interbody cages 
made of various materials, including metals, ceramics, and polymers. Metal implants 
have been widely used as spinal cages for ACDF procedures. In particular, titanium 
implants offer mechanical strength, maintenance of vertebral disc height, and  
are available in various forms including mesh and box implants [4]. However, 
there are concerns regarding the use of titanium implants due to their mismatched 
mechanical properties compared to native bone. The difference in elastic modulus 
between bone and titanium can cause stress shielding, weakening the surrounding 
bone and increasing risk of peri-prosthetic fractures [17]. Bioactive ceramics serve as 
an attractive alternative due to their demonstrated biocompatibility, osteoconductive 
potential, and availability [9]. Despite these advantages, varying porosity of ceramics 
can lead to brittleness, thus making them less ideal implants for load-bearing applica-
tions [18]. Finally, various polymers are used in biomedical applications due to their 
biocompatibility, chemical and mechanical stability, and wide ranging compositions. 
However, some polymers are not ideal for orthopedic implants due to their malleable 
nature and weak mechanical properties [19]. One polymer with desirable mechani-
cal properties is polyetheretherketone (PEEK). Compared to autograft, PEEK cages 
offer shorter operating time and reduced donor site morbidity [4]. This chapter will 
focus on the properties of structural allograft bone compared to conventional PEEK 
implants due to their similar mechanical properties and common use. Pre-clinical 
studies examining mechanical properties, osteoconduction and osseointegration, and 
clinical fusion rates in the cervical spine will be presented.
2.1 Structural allograft
Allograft bone, sourced from deceased human donors, is readily available and 
commonly used [20]. Allogenic bone grafts come in various forms, shapes, and 
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sizes, based on clinical need, and can be either structural or non-structural. The 
bone is typically processed by physical and chemical means to ensure safety, bio-
compatibility and clinical suitability. Processing steps can include physical shaping 
and resizing of the graft for a specific clinical purpose (e.g., an intervertebral body 
spacer), disinfection and sterilization, and preservation to increase shelf life and 
simplify storage.
Allograft use in bone grafting procedures dates back many decades, as evidenced 
by a nineteenth century publication from the Scottish surgeon William Macewen 
[21, 22]. He successfully reconstructed an infected humerus of a 4 year-old child 
using allograft tibial segments obtained while treating effects of rickets. Early in 
the twentieth century, Fred Albee published a book on bone graft applications, 
laying the foundation for a surge in bone transplantation procedures that is ongoing 
[23]. Allograft bone is now widely used for spinal, orthopedic, dental, and trauma 
applications. Notably, allograft usage in the treatment of degenerative cervical disc 
disease has increased from 14% in 1999 to 59% in 2008 [24]. Of particular inter-
est here, the use of structural allografts in ACDF procedures dates back as early as 
1958. Cloward described the use of frozen allograft bone in 46 patients undergoing 
ACDF [3]. A cylindrical iliac dowel, commonly known as the Cloward dowel, was 
implanted into the empty interbody space. Forty-four patients demonstrated com-
plete interbody fusion at 3–4 months post-operative. Numerous studies have since 
been published discussing the use of various structural allografts in ACDF proce-
dures [18]. Structural allografts continue to be used as interbody spacers due to their 
ability to support mechanical loads and resist failure. Such structural allografts 
are comprised of either cortical, cancellous or a combination of both cortical and 
cancellous bone. Cortical bone is more rigid and provides greater structural sup-
port, while cancellous bone confers less mechanical strength, but is more porous, 
providing an osteoconductive scaffold for neovascularization and osseointegration.
Infection due to allograft transplantation remains a risk, albeit rare. A report 
released by the Centers for Disease Control and Prevention (CDC) in 2005 estimated 
an overall allograft-associated infection rate of 0.0004%, emphasizing the unlikely 
event of allograft-associated disease transmission [25]. This number was developed 
before additional advanced tissue processing methods, including terminal sterilization, 
were implemented by many tissue providers. Organizations, such as the American 
Association of Tissue Banks (AATB) and the Food and Drug Administration (FDA), 
maintain standards for tissue banking, including donor acceptance criteria, tissue 
procurement and processing methods, and allograft storage [26, 27]. Additionally, 
FDA published the Current Good Tissue Practice (CGTP) Final Rule, effective in 2005, 
setting requirements aimed at “preventing the introduction, transmission and spread of 
communicable diseases” [28]. AATB and FDA guidelines ensure that human allograft 
tissues are both clinically suitable and safe. Through the combination of rigorous donor 
screening and tissue processing, risk of disease transmission is virtually eliminated.
2.2 Synthetics: polyetheretherketone (PEEK) cages
Polyetheretherketone (PEEK) is a non-absorbable, semicrystalline polymer 
processed through a variety of techniques including extrusion, or injection and 
compression molding [29, 30]. Chemically, PEEK is made up of an aromatic back-
bone, interconnected by ketone and ether functional groups [30]. The chemical 
structure of PEEK gives it distinct qualities such as: stability at high temperatures, 
resistance to chemical and radiation damage, strength and stiffness. PEEK is 
available in several configurations including neat (unfilled) and carbon-reinforced 
PEEK (CRPEEK). The addition of composite fillers, such as carbon fiber, provides 
those forms of PEEK with increased mechanical strength [30].
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Developed in 1978, PEEK was initially commercialized for industrial applica-
tions such as aircraft and turbine blades due to its high chemical and mechanical 
resistance [29, 31]. However, in the late 1980s, it emerged as a potential biomaterial 
for surgical implantation and rapidly gained acceptance as a medical device. In the 
late 1990s, PEEK was introduced as a spinal cage implant and has also been used for 
other orthopedic and dental applications [19]. PEEK cages have become a popular 
choice due to inherent biocompatibility and favorable mechanical properties com-
pared to traditional metal-based cages. PEEK has undergone numerous biocompat-
ibility and cytotoxicity tests in accordance with both FDA and ISO 10993 standards. 
Morrison et al. evaluated the response from mouse fibroblasts and rat osteoblasts 
in vitro and found PEEK to display excellent biocompatibility [32]. Rivard et al. 
demonstrated that PEEK particles implanted in New Zealand white rabbits elicited 
no apparent necrosis or swelling, leading the authors to suggest that it is “harmless” 
to the spinal cord [33].
Compared to other synthetic implants such as titanium cages, PEEK has an 
elastic modulus similar to that of native bone, thus reducing the potential impact of 
stress shielding on the bone healing process [19, 34]. Another advantage of PEEK is 
radiolucency which allows for radiographic assessment of fusion [35]. Furthermore, 
due to its ability to resist radiation damage, PEEK is able to be sterilized by electron 
beam or gamma irradiation. Despite noted advantages, several concerns have been 
raised due to how PEEK’s inert nature and low-surface energy might affect the 
body’s biological response. Adsorption of water at the implant surface plays an 
important role in protein-surface interactions, and thus cell-surface interactions, 
which can determine the success of an implant [36]. The hydrophobic nature of 
PEEK can potentially limit cellular adhesion. This undesirable property has been 
recently reported in studies finding that conventional smooth PEEK implants have 
limited osteoconductive properties and limited bone fixation at the implant inter-
face [29, 37]. For example, Phan et al. described a case in which a patient underwent 
anterior lumbar interbody fusion (ALIF) with a PEEK implant [38]. The authors 
found evidence of poor integration between the implant and surrounding bone 
causing the “halo-effect” on CT scans.
These issues have led to several modifications in an attempt to increase PEEK’s 
bioactivity, including surface coating with synthetic osteoconductive material such 
as titanium, increasing surface roughness and porosity through chemical modifica-
tions, and incorporating bioactive particles [34, 39]. Despite these promising modifi-
cations, conventional PEEK is still commonly used and is the focus in this chapter.
3. Engineering studies of PEEK and allograft
Interbody spacers require appropriate mechanical properties to be clinically 
effective. One important property is elastic modulus, the measure of resistance 
to deformation in response to applied stress. Mismatches in the elastic modulus 
between the surrounding vertebral bodies and an implant may lead to issues such 
as subsidence and stress shielding [40]. Clinically, these issues can cause complica-
tions such as pseudarthrosis and non-unions. Thus, it is ideal for an implant to 
have a similar elastic modulus as native bone. Heary et al. measured the elastic 
modulus and stiffness of various spinal interbody implants including neat and 
carbon-reinforced PEEK and cancellous and cortical bone [40]. The authors found 
that the elastic modulus of neat PEEK was similar to cancellous allograft bone, 3.84 
and 3.78 GPa, respectively (Figure 1). Similarly, carbon-reinforced PEEK demon-
strated a comparable elastic modulus to cortical allograft bone, 17.94 and 14.64 GPa, 
respectively. The study demonstrates the similar elastic modulus of allograft and 
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PEEK implants and contrasts with the stiffer stainless steel, titanium, and cobalt-
chrome materials.
The success of a spinal fusion procedure depends, in part, on the mechanical 
strength of the interbody spacer. Failure of the spacer can lead to graft subsidence 
and non-union. Native vertebral bodies have been reported to withstand average 
compressive strengths up 2400 N for cervical and 8600 N for lumbar joints [41, 42]. 
It is desirable for interbody spacers to withstand a compressive strength comparable 
to that of the relevant autologous bone in that surgical procedure (e.g., cervical vs. 
lumbar). Since structural allografts are typically processed to disinfect or sterilize, 
and to preserve for storage before use, these methods have the potential to alter 
clinically relevant properties. The biomechanical strength of several configura-
tions of structural bone allografts was assessed following disinfection using one 
such method, the proprietary Allowash® process (United States Patents 5,556,379; 
5,820,581; 5,977,034; 6,024,735). In addition, samples were tested with or with-
out a sterilizing dose of gamma irradiation performed at ultra-low temperatures 
(Figure 2). The results indicate that bone grafts can be disinfected and retain a 
strength greater than that of pertinent vertebral bodies, but can also be sterilized 
under controlled conditions without negative impact on the clinically relevant 
Figure 1. 
Elastic modulus of all materials (*p < 0.05; **p < 0.01). Reprinted with permission from Heary et al. [40].
Figure 2. 
Compressive strength of disinfected and irradiated vs. disinfected only structural bone allografts used in spinal 
fusion procedures. Compressive strength was defined as the maximum load that the graft could withstand 
before graft failure. Disinfected structural allografts were divided into either non-irradiated or irradiated 
groups, with a targeted absorbed dose of 15 kGy. Irradiation did not significantly alter the compressive strength 
of any of the structural allografts.
Bone Grafts
6
characteristics of the bone. Additionally, it has been separately demonstrated that 
moderate doses of irradiation (up to 28.5 kGy) performed at ultra-low temperatures 
do not alter the compressive strength or elastic modulus of structural allografts 
compared to non-irradiated controls [43].
Likewise, storage conditions can potentially alter properties of structural bone 
allografts before use. Traditionally, bone grafts have been provided frozen, with 
storage at −20°C, or freeze-dried, which allows for storage at room temperature. 
Frozen grafts require special shipping and storage, and must be thawed prior 
to use. Freeze-dried allografts can be stored at room temperature, but require 
rehydration, which may not restore the native biomechanical properties of the 
graft. More recently, a glycerol-based preservation solution was developed to 
allow storage of grafts at room temperature [44]. The flexural strain (i.e., elastic-
ity) and compressive strength of various structural bone allografts preserved by 
either freezing, freeze-drying, or glycerol-based preservation were evaluated. The 
results demonstrate that the frozen and glycerol-preserved groups were not sig-
nificantly different, but did display significantly greater flexural strain compared 
to freeze-dried tissue, even after the freeze-dried bone was rehydrated up to 60 
minutes (Figure 3A). The compressive strengths of different structural allografts 
that were either freeze-dried or glycerol-preserved (Figure 3B) were found to be 
unaltered by the preservation method for each type of graft. These results dem-
onstrate that the processing of allograft bone, including disinfection, sterilization 
by irradiation and varying preservation methods, does not significantly impair 
clinically relevant characteristics, notwithstanding the increased brittle nature of 
freeze-dried bone.
4. Pre-clinical literature review: in vivo models
In addition to testing mechanical properties, it is also important to evaluate 
the biocompatibility of bone graft substitutes. Animal models are a common and 
useful tool to evaluate the in vivo response to implantable materials prior to clinical 
application. Animal studies have demonstrated fibrous tissue growth and lack of 
osseointegration related to the use of PEEK implants.
Figure 3. 
Biomechanical properties of structural allografts preserved by different methods. Different types of disinfected 
structural bone allografts were preserved by either freezing, freeze-drying or glycerol preservation, followed 
by irradiation with a targeted absorbed dose of 15 kGy. Panel (A) shows the average flexural strain of cortical 
bone allografts preserved by the different approaches. The glycerol-preservation and frozen groups were not 
significantly different, but both demonstrated significantly greater average maximum flexural strain compared 
to the freeze-dried group. Modified and reprinted with permission from Samsell et al. [44] according to the 
Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/
legalcode). (B) Average compressive strength of structural allografts that were either freeze-dried or preserved 
using a glycerol-based solution. The compressive strength was not different between the freeze-dried and 
glycerol-preserved groups for all three graft types.
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In a technical note, Phan et al. described PEEK’s poor integration with the 
surrounding bone, producing a “PEEK-Halo” effect [38]. This phenomenon is 
represented by a halo appearance between the implant and bone graft on a CT scan. 
The authors placed conventional PEEK (c-PEEK) and Ti-sprayed PEEK implants in 
cortical bone and cancellous bone of adult sheep tibia. Histological analysis of the 
c-PEEK implant showed a fibrous tissue layer and a gap on the PEEK-bone interface 
(Figure 4). The authors suggest this may be due to inflammatory factors and/or the 
interaction between PEEK and osteoblastic differentiation. In a cervical interbody 
fusion model in adult sheep, authors compared the bone-implant interface of conven-
tional PEEK (c-PEEK) and Hydroxyapatite coated PEEK (HA-PEEK) [37]. Micro-CT 
analysis demonstrated less new bone formation in the c-PEEK group at 6 weeks post-
implantation. Furthermore, histological analysis showed a fibrous tissue interface 
between bone and c-PEEK implants at 6 and 12 weeks post-implantation. Walsh et al. 
likewise compared the mechanical and histologic properties of conventional PEEK 
and Ti-PEEK at the bone-implant interface in a sheep model [45]. Sites implanted 
with c-PEEK appeared static with no bone response. While, encouragingly, Ti-PEEK 
exhibited in-growth of bone, that is not the focus of this chapter. PEEK-bone implant 
interface contained a fibrous tissue layer and a gap at 4 and 12 weeks. Direct bone 
contact for the c-PEEK implants in cancellous bone was minimal at 4 weeks (4.8%) 
and improved at 12 weeks, but only reached 11.5%. This in vivo study is yet another 
example of fibrous tissue seen at the PEEK interface.
The use of structural allografts in ACDF procedures is well documented, with 
reported fusion rates similar to that of autologous bone [15, 16]. In vivo osseointe-
gration of bone was assessed using a calvarial defect model in athymic rats [44]. A 
portion of the rat’s skull was removed to create a critical size defect, which cannot 
close on its own. Following creation of the defect site, the investigators implanted 
human cortical and cancellous bone discs that were preserved by either freezing, 
freeze-drying, or glycerol-based preservation. At 1 week post-implantation, there 
Figure 4. 
Histology of PEEK/bone interface at 4 weeks post-implantation into a sheep tibia model. (A) Presence of 
fibrous tissue (white arrow) between the PEEK implant and adjacent bone—the rim of fibrous tissue results 
in the halo effect seen on CT imaging. (B) Titanium (Ti)-PEEK/bone interface demonstrating on-growth and 
ingrowth of bone at the Ti-PEEK/bone interface, with no radiolucent rim evident on CT imaging. Reprinted 
with permission from Phan et al. [38].
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was apparent soft tissue infiltration in all experimental groups, consistent with an 
early post-operative response. These findings support the biocompatibility of the 
bone grafts. Additionally, at 6 weeks post-implantation, the authors observed areas 
of osseointegration similar to autograft (Figure 5).
5. Clinical data: fusion, nonunion, and pseudarthrosis rates
Both PEEK and allograft spinal implants have a long history of use in ACDF 
procedures. While mechanical and pre-clinical results can help predict clinical 
performance, this is ultimately determined through clinical outcomes. Many studies 
rely upon radiographic fusion to determine clinical success. According to Zdeblick 
and Phillips, “most published reports use the ‘fusion’ criteria required by the FDA, 
including motion of less than 5° on flexion-extension radiographs and an absence 
of lucencies around the cages or cage migration” [46]. Some studies also include 
pseudarthrosis rates. In the following section, we will compare clinical outcomes for 
allograft and PEEK implants.
Historically, autograft has been considered the gold standard for spinal fusion 
procedures, and therefore, it is used as the control to which structural allografts or 
PEEK implants have been compared. In a retrospective review, investigators evalu-
ated radiographic fusion in 66 patients who underwent one-level ACDF with auto-
graft (n = 31) or frozen tricortical iliac crest allograft spacers (n = 35), both with 
anterior plate fixation [16]. Radiographic outcomes were assessed at an average of 
12 months follow-up. One hundred percent of patients in the allograft group dem-
onstrated fusion compared to the 90% of patients in the autograft group, although 
the difference was not statistically significant. Three patients in the autograft group 
showed evidence of non-union. The authors suggested that the use of allograft can 
achieve high fusion rates, while avoiding complications associated with autograft, 
such as donor site pain. In a similar study, radiographic fusion was assessed in 80 
patients who underwent multi-level ACDF procedures using autologous (n = 45) 
or allogeneic (n = 35) tricortical iliac crest grafts [15]. Radiographic outcomes 
were assessed in all patients at an average follow-up of 16 months. Successful bone 
fusion occurred in 100 and 94% of patients in the autograft and allograft group, 
respectively. Pseudarthrosis occurred in two patients in the allograft group, but was 
not statistically significant. The authors concluded that allograft can produce solid 
bone fusion similar to autograft without the associated donor site pain. Finally, in 
a prospective study, Cho et al. compared the radiographic outcomes of PEEK cages 
Figure 5. 
(a) Glycerol-preserved cancellous bone in a tight-fit rat calvarial defect. The scale is 500 μm. (b) Freeze-dried 
cortical bone in a tight-fit rat calvarial defect at 6 weeks. The scale is 500 μm. Black arrows mark complete 
bone bridge formation. Blue arrows indicate soft tissue infiltrate. Green arrows mark osseointegration. H, host 
bone; I, implant bone. Reprinted with permission from Samsell et al. [44] according to the Creative Commons 
Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/legalcode).
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filled with autologous iliac bone marrow vs. autologous iliac crest graft only in 80 
patients who underwent ACDF, with the number of levels ranging from 1 to 3 [47]. 
The study revealed 93% fusion in the autograft only group and 100% fusion rate in 
autograft filled PEEK cage group at an average follow-up of 10 months. It should be 
noted that the high fusion rate demonstrated by the PEEK group could potentially 
be associated with inherent bone healing properties of autograft within the cage.
Structural allografts have been used for decades to treat degenerative cervical 
disc disease. Numerous studies have evaluated radiographic fusion rates following 
use of structural bone allografts in ACDF procedures. Abla et al. prospectively 
evaluated 74 patients who were diagnosed with clinically significant cervical spinal 
stenosis or spondylosis and required ACDF surgery [48]. The investigators used a 
corticocancellous composite interbody spacer allograft (Figure 6) combined with 
cervical plate fixation. One-level fusion was performed in 34 patients, two levels in 
23 patients, three levels in six patients, and four levels in one patient. Early fusion 
(at 1–3 months post-operative) was seen in 53% of the patients and by 12 months, 
100% of the patients had fusion (Figure 6). The authors reported no graft failures, 
and an overall patient satisfaction of 90% at 12 months follow-up.
Another study, conducted by Graham et al. prospectively compared fusion rates 
using either freeze-dried or glycerol-preserved Cloward dowel allografts in ACDF 
procedures [49]. The study evaluated 86 patients with random assignment to either 
freeze-dried (n = 39) or glycerol-preserved (n = 47) groups (82 and 100 levels, 
respectively). Radiographic assessment at 6 months follow-up confirmed an overall 
fusion rate of >95% at all levels. Similarly, Rodway and Gander compared the use of 
glycerol-preserved vs. frozen interbody corticocancellous composite allografts in 67 
patients undergoing ACDF procedures, with the number of levels ranging from 1 to 
4 and a 1-year minimum follow-up [50]. Radiographic results demonstrated fusion 
in 38% of glycerol-preserved and 42% of frozen allografts at 3 months follow-up, 
and 100% fusion in both groups at 12 months (Table 1). Of note, the structural 
allografts used in each of these studies were sterilized by a low dose of gamma irra-
diation at ultra-low temperatures. Therefore, the combined results demonstrate the 
clinical effectiveness of structural allografts in ACDF surgery, regardless of method 
of preservation or treatment with a sterilizing dose of irradiation.
Figure 6. 
(A) Structural interbody spacer with cancellous bone sandwiched between two plates of cortical bone. (B) Lateral 
X-ray 6 months after ACDF was performed in a 47-year old woman from C4-C5 using the structural interbody 
spacer shown. Complete fusion and good alignment were achieved. Modified and reprinted with permission from 
Abla et al. [48].
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In a separate retrospective study, Muzevic et al. evaluated 154 patients who 
underwent a first-time ACDF surgery for treatment of cervical degenerative disc 
disease over a 3-year period [51]. One-level fusion was performed in 48 patients, 
two-level in 56 patients, three-level in 47 patients, and four-level in three patients 
using either cortical or corticocancellous structural allografts, along with demin-
eralized bone matrix and cervical plating. Solid fusion was achieved in 98% 
of patients at a mean follow-up of 6 months, with improved overall treatment 
outcomes in 82% of patients. Finally, Yue et al. reviewed clinical and radiological 
outcomes in 71 patients who had ACDF surgery performed using structural freeze-
dried fibular allografts an average of 7.2 years prior to the review [52]. The authors 
found that symptoms remained resolved in more than 82% of patients. They 
observed fusion in 93% of disc spaces, which was comparable to reported fusion 
rates for autograft [15, 16, 47, 53, 54]. While approximately 17% of the patients 
required revision surgery, the authors state that this rate is comparable to that fol-
lowing ACDF performed with autograft. Therefore, they attribute this revision rate 
to be a reflection of “normal” degeneration with age and not to use of allograft.
Several studies have assessed the clinical outcomes of ACDF procedures with 
the use of PEEK cages. In a prospective study, investigators assessed bone fusion in 
52 patients who underwent anterior cervical discectomy with empty PEEK cages. 
One-level surgery was performed in 44 patients and 2-level surgery in eight patients 
[55]. Based on radiographic analyses, the authors confirmed bone fusion at 43 
treated levels (72%) at an average of 16 months. The authors note the low fusion 
rates of empty PEEK cages, but stated that the lack of fusion did not affect clinical 
outcomes. Similarly, Suess et al. evaluated the clinical and radiographic outcomes 
of 292 patients who received empty PEEK cages for single-level ACDF procedures 
[56]. PEEK demonstrated radiographic fusion in 126 patients (43%) at 6 months, 
214 patients (73%) at 12 months, and 241 patients (83%) at 18 months. The authors 
noted that slow and incomplete radiographic fusion could be attributed to the use of 
empty PEEK cages, and therefore did not recommend their use. Furthermore, they 
suggest this incomplete fusion may lead to reduced improvement in pain and pos-
sible disability. Finally, Kim et al. retrospectively evaluated 68 patients who under-
went two and three-level ACDF with PEEK packed with demineralized bone matrix 
[57]. At an average follow-up of 28 months, PEEK demonstrated 81% overall fusion 
rate, which is less than reported levels for both autograft and structural allograft.
In a retrospective review, Krause et al. looked at 127 patients who underwent 
one-level ACDF with structural allograft (composite (61/71), cortical (8/71), or 
cancellous (2/71)) or PEEK cages to examine the incidence of pseudarthrosis as 
determined by radiography [58]. Fifty six patients (44%) received PEEK implants 
while 71 (56%) received structural allografts. All PEEK cages were filled with 
allogeneic demineralized bone matrix (DBM) or local autograft. The PEEK cohort 
demonstrated a higher rate of radiographic pseudarthrosis at one or more years 
Table 1. 
Fusion rates by number of patients*. Source: “Reprinted with permission from Rodway and Gander [50], 
according to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/
licenses/by/4.0/legalcode)”.
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after follow-up compared to the allograft cohort, 52 vs. 10% (p < 0.001), respec-
tively (Figure 7). The investigators concluded that there was a five-fold higher 
incidence of pseudarthrosis in patients with PEEK cages, and almost double the rate of 
subsequent revision. Furthermore, the investigators suggested PEEK’s inability to 
integrate with organic bone is due to its bio-inertness.
In a similar study, Teton et al. compared pseudarthrosis rates of 62 consecutive 
patients who underwent multi-level ACDF with structural allograft or PEEK cages, 
with at least 1 year follow-up [59]. Of 62 patients, 31 received PEEK implants, and 
31 received structural allograft. Within the PEEK group, 20 (65%) patients dem-
onstrated radiographic evidence of pseudarthrosis, compared to six (19%) patients 
implanted with structural allograft (p < 0.001), demonstrating over three-fold higher 
incidence of pseudarthrosis rates with PEEK. Furthermore, four patients implanted 
with PEEK required re-operation due to pseudarthrosis (13%), compared to 
zero patients with allograft (p = 0.014). Additionally, in a retrospective database 
review, authors analyzed 6130 patients who underwent ACDF with allograft (4063 
patients) or intervertebral cages (2067 patients) to compare nonunion rates after 
Figure 7. 
Sagittal X-ray films obtained in a patient with a PEEK interbody graft and pseudarthrosis (left) and a patient 
with a structural allograft implant (right) healed 1 year after surgery. Reprinted with permission from Krause 
et al. [58].
*PEEK, titanium, mesh, or porous (unstratified due to nature of data base).
Table 2. 
Nonunion Rates Between Structural Allograft and Cages*. Source: Reprinted with permission from Pirkle et al. [60].
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Author and year Number of 
levels
Graft type Number of patients Time of fusion 
assessment
Fusion rate 
(%)
Pseudarthrosis rate 
(%)
Samartzis et al. 
[16]
2- and 3-level Autograft 45 16 months 100 N/A
Structural allograft (tricortical iliac crest) 35 94
Samartzis et al. 
[15]
1-level Autograft 31 12 months 90 N/A
Structural allograft (tricortical iliac crest) 35 100
Cho et al. [47] Multilevel Autograft 40 Avg. 10 months 93 N/A
PEEK + autograft 40 100
Abla et al. [48] Multilevel Structural allograft (corticocancellous 
composite)
74 1–3 months 53 N/A
12 months 100
Graham et al. [49] Multi-level Allograft (Cloward dowel, freeze-dried) 39 6 months 95 N/A
Allograft (Cloward dowel, 
glycerol-preserved)
47 98
Rodway and 
Gander [50]
Multi-level Allograft (corticocancellous composite, 
glycerol-preserved)
29 3 months 38 N/A
18 12 months 100
Allograft (corticocancellous composite, 
frozen)
38 3 months 42
25 12 months 100
Muzevic et al. [51] Multi-level Allograft (cortical or 
corticocancellous + DBM)
154 Avg. 6 months 98 N/A
Yue et al. [52] Multi-level Allograft (fibular segment, freeze-dried) 71 Avg. 7 years 93 17 (“normal 
degeneration”)
Pechlivanis et al. 
[55]
1- and 2-level PEEK 52 Avg. 16 months 72 28 (nonunion)
Suess et al. [56] 1-level PEEK 292 6 months 43 N/A
12 months 73
18 months 83
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Author and year Number of 
levels
Graft type Number of patients Time of fusion 
assessment
Fusion rate 
(%)
Pseudarthrosis rate 
(%)
Kim et al. [57] 2- and 3-level PEEK + DBM 68 Avg. 28 months 81 N/A
Krause et al., [58] 1-level PEEK + DBM or autograft 56 (47 DBM; 9 autograft) Avg. 21 months N/A 52
Structural allograft (composite, cortical, or 
cancellous)
71 (61 composite; 8 cortical; 
2 cancellous)
Avg. 16 months N/A 10
Teton et al. [59] Multi-level PEEK 31 1 year N/A 65
Structural allograft 31 N/A 19
Pirkle et al. [60] Multi-level Intervertebral cages 2067 1 year N/A 5
Allograft 4063 N/A 2
Table 3. 
Clinical fusion and pseudarthrosis rates following ACFD using autograft, structural allograft, or PEEK cages.
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1 year post-operative [60]. Cages were unable to be stratified by type and may have 
been “PEEK, titanium, mesh, or porous.” Patients were stratified by the number 
of levels treated, tobacco use, and diabetic conditions. Overall nonunion rates 
were significantly higher in the cage group (5.32%) than in allograft group (1.97%) 
(p < 0.0001). Notably, patients receiving intervertebral cages showed higher rates 
of nonunion regardless of other factors such as, levels treated, tobacco use, and 
diabetes (Table 2).
6. Summary
While autograft use is common for bone grafting procedures, it is associated 
with limitations, including donor site morbidity, limited quantities, and unsatis-
factory biological activity. For ACDF, autograft use has steadily declined in favor 
of alternatives, primarily structural bone allografts and PEEK cages [18, 30]. 
Favorably, each has mechanical properties similar to autograft, with comparable 
elastic modulus and sufficient strength for intended applications. However, in vivo 
models demonstrate lack of osseointegration for PEEK, as well as fibrous tissue 
growth. Poor integration can lead to graft subsidence and pseudarthrosis, and 
ultimately pain, immobility and sensory loss. In contrast, structural allografts act as 
an osteoconductive scaffold demonstrating osseointegration in a rat model and have 
a long history of successful clinical use. These differences are reflected in clinical 
outcomes, as detailed in this chapter and summarized in Table 3. As shown, fusion 
rates when using PEEK cages were generally lower than when structural allografts 
were used. Moreover, the use of PEEK cages, and cages in general, in ACDF surgery 
presented a significantly higher rate of pseudarthrosis vs. structural allografts, lead-
ing to a greater rate for the need for subsequent revision surgery.
Due to lack of osseointegration of PEEK reported both pre-clinically and clini-
cally, researchers have modified its surface or sought other materials in attempt to 
improve clinical outcomes. There are promising advances in porous and titanium 
coatings and clinical efficacy is being assessed.
In conclusion, although conventional PEEK cages have similar elastic modulus 
as structural allografts and autografts, they display poorer osseointegration charac-
teristics compared to human bone implants. Comparative clinical analyses indicate 
that structural allografts yield higher fusion rates and lower incidence of pseudar-
throsis than conventional PEEK cages in ACDF procedures.
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